A novel method, COAMATIC® plasmin inhibitor, for the specific determination of Plasmin Inhibitor activity in plasma

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 165-167

  Clason, S Billing ^a   Meijer, P ^b   Kluft, C ^b   Ersdal, E ^a  

^a Chromogenix AB   (Sweden)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN;

ASSAY; CONFERENCE PAPER; FIBRINOLYSIS; HUMAN; PLASMA; PRIORITY JOURNAL;

EID: 0029855332     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80078-6     Document Type: Conference Paper

References (9)

1. Collen D, Wiman B 1978 Fast-acting plasma inhibitor in human plasma. Blood 51: 563-569
2. Booth N. A, 1994 The natural inhibitors of fibrinolysis. Haemostasis and Thrombosis,vol 1, ed.3. edt. Bloom A. L, Forbes C.H, Thomas D.P, Tuddenham E.G.D,699-717
3. 2-plasmin inhibitor levels in liver diseases. Clin Chim Acta 84: 99-105
4. 2-Plasmin Inhibitor is among acute phase reactants. Thromb Res 17: 527-532
5. 2-Antiplasmin on the Automated Coagulation Analyzer MLA Electra 1000C. Fibrinolysis 8: Suppl.2, 160-162
6. Woodham B 1995 Letter to the Editor. Fibrinolysis 9:129-131
7. 2-Antiplasmin activity measurement in plasma. Thromb Haemostasis 73:1145, abstract 938
8. Meijer P, Kluft C 1996 Criteria for an automated specific plasmin inhibition test (SPIT) in human plasma, Fibrinolysis 1996; 10 suppl. 2: 121-123
9. 2-Antiplasmin activity. In : Jespersen J, Bertina R M, Haverkate F (eds), ECAT Assay Procedures, A manual of laboratory techniques. Kluwer Academic Publishers, Dordrecht, The Netherlands, 165-171